Higher Burden of Comorbidity Linked to Worse Clinical Outcomes in MS

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 23, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 23, 2024 -- For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according to a study published online Sept. 18 in JAMA Neurology to coincide with the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis, held from Sept. 18 to 20 in Copenhagen, Denmark.

Amber Salter, Ph.D., from UT Southwestern Medical Center in Dallas, and colleagues examined the association of comorbidities with disease activity in clinical trials of disease-modifying therapies in populations with MS in a two-stage meta-analytic approach. The cohort study included individual participant data for 16,794 participants with MS from 17 phase 3 clinical trials of MS disease-modifying therapies.

The researchers found that 61.0 percent of the pooled trials had evidence of disease activity (EDA) during the two-year follow-up period. After adjustment for multiple factors, compared with no comorbidity, the presence of three or more comorbidities was associated with an increased risk for EDA (adjusted hazard ratio, 1.14). The risk for EDA was also increased with presence of two or more versus no cardiometabolic conditions (adjusted hazard ratio, 1.21). Increased hazard of EDA was seen in association with one psychiatric disorder (adjusted hazard ratio, 1.07).

"As these findings are coherent with observational studies using different study designs and data sources, evidence suggests that clinicians need to routinely address comorbidity in people with MS," the authors write.

Several authors disclosed ties to the biopharmaceutical industry; the study was based on research using data from pharmaceutical companies.

Abstract/Full Text

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-24 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords